United Kingdom
# |
Name |
Net Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 5.96 B
|
Dec. 31, 2023 | USD 129.77 | -1.69% |
|
United Kingdom |
|
2 |
USD 4.35 B
|
March 31, 2024 | USD 10.94 | 1.86% |
|
United Kingdom |
|
3 |
USD 13.61 M
|
Dec. 30, 2023 | USD 72.03 | -1.91% |
|
United Kingdom |
|
4 |
USD 10.25 M
|
June 30, 2024 | USD 39.06 | 2.49% |
|
United Kingdom |
|
5 |
USD 10.00 M
|
June 30, 2024 | USD 17.38 | -3.70% |
|
United Kingdom |
|
6 |
USD 7.03 M
|
Dec. 31, 2023 | USD 5.68 | 0.09% |
|
United Kingdom |
|
7 |
USD 5.29 M
|
April 30, 2024 | USD 0.64 | 0.47% |
|
United Kingdom |
|
8 |
USD 5.20 M
|
Aug. 31, 2023 | USD 0.16 | -0.68% |
|
United Kingdom |
|
9 |
USD 2.99 M
|
Dec. 31, 2023 | USD 0.31 | 0.09% |
|
United Kingdom |
|
10 |
USD 1.32 M
|
March 31, 2024 | USD 0.78 | -0.69% |
|
United Kingdom |
|
11 |
USD -16.83 K
|
March 31, 2024 | USD 1.03 | NA |
|
United Kingdom |
|
12 |
USD -1.20 M
|
Nov. 30, 2023 | USD 0.03 | 0.09% |
|
United Kingdom |
|
13 |
USD -1.43 M
|
June 30, 2024 | USD 0.31 | 0.09% |
|
United Kingdom |
|
14 |
USD -1.61 M
|
June 30, 2024 | USD 0.10 | 0.09% |
|
United Kingdom |
|
15 |
USD -1.71 M
|
Dec. 31, 2023 | USD 0.70 | -2.31% |
|
United Kingdom |
|
16 |
USD -1.82 M
|
March 31, 2024 | USD 0.15 | 0.09% |
|
United Kingdom |
|
17 |
USD -1.98 M
|
Dec. 31, 2023 | USD 0.05 | 0.09% |
|
United Kingdom |
|
18 |
USD -2.07 M
|
Dec. 31, 2023 | USD 0.02 | 2.68% |
|
United Kingdom |
|
19 |
USD -2.22 M
|
Dec. 31, 2023 | USD 0.04 | -9.47% |
|
United Kingdom |
|
20 |
USD -2.59 M
|
Dec. 31, 2023 | USD 0.21 | 0.09% |
|
United Kingdom |
|
21 |
USD -2.68 M
|
Sept. 30, 2024 | USD 0.14 | 0.09% |
|
United Kingdom |
|
22 |
USD -2.81 M
|
March 31, 2024 | USD 0.11 | -6.40% |
|
United Kingdom |
|
23 |
USD -3.11 M
|
Dec. 31, 2023 | USD 0.05 | 1.50% |
|
United Kingdom |
|
24 |
USD -3.64 M
|
June 30, 2024 | USD 0.19 | -3.04% |
|
United Kingdom |
|
25 |
USD -3.72 M
|
Dec. 31, 2023 | USD 0.04 | -14.59% |
|
United Kingdom |
|
26 |
USD -4.20 M
|
May 31, 2024 | USD 0.24 | -4.72% |
|
United Kingdom |
|
27 |
USD -4.33 M
|
June 30, 2024 | USD 0.27 | 2.36% |
|
United Kingdom |
|
28 |
USD -4.46 M
|
Dec. 31, 2023 | USD 0.49 | 0.09% |
|
United Kingdom |
|
29 |
USD -5.00 M
|
Dec. 31, 2023 | USD 0.06 | 1.92% |
|
United Kingdom |
|
30 |
USD -6.73 M
|
March 31, 2024 | USD 2.29 | -3.78% |
|
United Kingdom |
|
31 |
USD -7.32 M
|
April 30, 2024 | USD 0.11 | -4.08% |
|
United Kingdom |
|
32 |
USD -8.51 M
|
Dec. 31, 2023 | USD 4.80 | 0.73% |
|
United Kingdom |
|
33 |
USD -8.73 M
|
Dec. 31, 2023 | USD 0.05 | -16.59% |
|
United Kingdom |
|
34 |
USD -8.93 M
|
Dec. 31, 2023 | USD 0.04 | 0.09% |
|
United Kingdom |
|
35 |
USD -8.95 M
|
June 30, 2024 | USD 0.03 | -4.36% |
|
United Kingdom |
|
36 |
USD -9.01 M
|
Dec. 31, 2023 | USD 4.18 | -2.79% |
|
United Kingdom |
|
37 |
USD -9.08 M
|
Dec. 31, 2023 | USD 0.20 | 0.09% |
|
United Kingdom |
|
38 |
USD -9.75 M
|
Dec. 31, 2023 | USD 15.26 | 0.09% |
|
United Kingdom |
|
39 |
USD -10.70 M
|
Dec. 31, 2023 | USD 0.03 | -2.14% |
|
United Kingdom |
|
40 |
USD -10.88 M
|
Dec. 31, 2023 | USD 0.71 | 0.09% |
|
United Kingdom |
|
41 |
USD -13.21 M
|
Sept. 30, 2023 | USD 0.01 | -33.27% |
|
United Kingdom |
|
42 |
USD -15.69 M
|
Dec. 31, 2023 | USD 0.13 | -2.30% |
|
United Kingdom |
|
43 |
USD -25.61 M
|
Dec. 31, 2023 | USD 0.14 | 0.09% |
|
United Kingdom |
|
44 |
USD -27.61 M
|
Dec. 31, 2023 | USD 0.23 | 1.46% |
|
United Kingdom |
|
45 |
USD -29.47 M
|
Dec. 31, 2023 | USD 3.06 | -8.38% |
|
United Kingdom |
|
46 |
USD -31.74 M
|
Dec. 31, 2023 | USD 0.62 | -2.80% |
|
United Kingdom |
|
47 |
USD -35.16 M
|
Dec. 31, 2023 | USD 1.04 | 1.96% |
|
United Kingdom |
|
48 |
USD -50.90 M
|
June 30, 2024 | USD 0.09 | 2.54% |
|
United Kingdom |
|
49 |
USD -52.78 M
|
Sept. 30, 2024 | USD 0.36 | 3.24% |
|
United Kingdom |
|
50 |
USD -54.37 M
|
Dec. 31, 2023 | USD 48.44 | 3.75% |
|
United Kingdom |
The Biotechnology company in United Kingdom with the highest Net Income is AstraZeneca PLC (LSE: AZN.L) at USD 5.96 B.
The Biotechnology company in United Kingdom with the lowest Net Income is Clarivate Plc (NYSE: CLVT) at USD -911.20 M.
The top 10 Biotechnology companies in United Kingdom by Net Income are AstraZeneca PLC, Roivant Sciences Ltd., NIOX Group Plc, Bioventix PLC, Genus plc, Science Group plc, SDI Group plc, Oncimmune Holdings plc, EKF Diagnostics Holdings plc and ECO Animal Health Group plc.
The bottom 10 Biotechnology companies in United Kingdom by Net Income are Clarivate Plc, Autolus Therapeutics plc, Oxford Biomedica plc, Oxford Nanopore Technologies plc, Bicycle Therapeutics plc, Barinthus Biotherapeutics plc, Immunocore Holdings plc, Silence Therapeutics plc, Verona Pharma plc and Benchmark Holdings plc.